MetroLatinoUSA

13

Dic

By MetroLatinoUSA

BW

QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer

therascreen® KRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI® (adagrasib) KRAS mutations in NSCLC reflect a large, underserved patient population with an unmet need for innovative treatment options 4th approval of the kit adds…

Leer más...

13

Dic

By MetroLatinoUSA

BW

AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting

VIENNA--(BUSINESS WIRE)--AOP Health announced its latest updates on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from AOP Health´s CONTINUATION-PV study (Reference Kiladjian et al. ASH 2022) and the LOW-PV trial, which is an independent investigator-initiated trial supported by AOP Health (Reference Barbui et al. ASH 2022) presented at ASH…

Leer más...

13

Dic

By MetroLatinoUSA

BW

RtBrick Brings High Availability to Disaggregated Broadband Networks

Software routing pioneer separates control and user planes across multiple systems to minimize network outages FREMONT, Calif.--(BUSINESS WIRE)--RtBrick today announced it has added high availability capabilities to its routing software to help re-establish network services with only minimal disruption. Broadband access is a critical resource, and it has become increasingly…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Botify Expands Executive Leadership and Advisory Bench in Response to Widespread Industry Push to Leverage the Power of Organic Search

Appointment of seasoned leaders in NEMEA, SEMEA signifies the company’s response to robust industry growth and recognition of organic search as a strategic and sustainable performance marketing channel NEW YORK--(BUSINESS WIRE)--Botify, the leading enterprise software company for performance-driven organic search, is closing out 2022 by appointing a series of global…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Kantata is Selected by Deloitte Central Europe as its Software Provider

Kantata’s professional services automation solution to assist Deloitte CE in daily operations IRVINE, Calif. & LONDON--(BUSINESS WIRE)--Kantata, the leading global supplier of purpose-built technology for professional services, today announced that Deloitte Central Europe, an industry-leading audit, tax and consulting service firm, has chosen Kantata to support its professional services and…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Sierra Space Successfully Completes Series of Major Development Milestones for First Commercial Space Station

Second Sub-Scale LIFE™ Habitat Test Article Exceeds NASA Certification Requirements After Ultimate Burst Pressure (UBP) Test LOUISVILLE, Colo.--(BUSINESS WIRE)--Sierra Space, a leading commercial space company building the first end-to-end business and technology platform in space, announced today that the company’s LIFE™ habitat (Large Integrated Flexible Environment) has successfully completed its…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Insurance Customers Want Convenience and Climate Action, but It Must Be Built on Trust

Data-driven future of insurance will only become reality if insurers can convince customers on data collection benefits DUBLIN & LONDON--(BUSINESS WIRE)--Consumers are beginning to look for the same convenience from their insurance companies as they are in other areas of their lives. That is according to a report* published by…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Mirum Pharmaceuticals’ LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and Older

- First and only medication approved in both the U.S. and Europe to treat cholestatic pruritus in patients with Alagille syndrome. - Approval supported by more than six years of LIVMARLI data demonstrating improvements in transplant-free survival, serum bile acids, growth, xanthomas, and quality of life. - Expected to launch…

Leer más...

13

Dic

By MetroLatinoUSA

BW

Advicenne Obtains Orphan Drug Designation for ADV7103 in the United States for the Treatment of Distal Renal Tubular Acidosis (dRTA)

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, announced today that ADV7103, its proprietary drug currently in Phase III in the United States, has been granted Orphan Drug Designation (ODD)…

Leer más...

13

Dic

By MetroLatinoUSA

BW

One in Five Security Professionals Won’t Bet a Chocolate Bar They Could Prevent a Damaging Breach

Ivanti research also uncovered that CEOs, vice presidents and other executives are four times more likely to be victims of phishing compared to other employees SALT LAKE CITY--(BUSINESS WIRE)--Ivanti, the provider of the Ivanti Neurons automation platform that discovers, manages, secures, and services IT assets from cloud to edge, today…

Leer más...